These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36688372)

  • 1. Prognostic Implication of Mitral Valve Disease and Its Progression in East Asian Patients With Hypertrophic Cardiomyopathy.
    Kim DY; Seo J; Cho I; Hong GR; Ha JW; Shim CY
    J Am Heart Assoc; 2023 Feb; 12(3):e024792. PubMed ID: 36688372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiographic and clinical outcomes of patients undergoing septal myectomy plus anterior mitral leaflet extension for hypertrophic cardiomyopathy.
    Fernandez R; Nappi F; Horvath SA; Guigui SA; Mihos CG
    Rev Cardiovasc Med; 2021 Sep; 22(3):983-990. PubMed ID: 34565099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of Jet Direction on Doppler Echocardiography in Identifying the Etiology of Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy.
    Hang D; Schaff HV; Nishimura RA; Lahr BD; Abel MD; Dearani JA; Ommen SR
    J Am Soc Echocardiogr; 2019 Mar; 32(3):333-340. PubMed ID: 30598365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and pooled analysis of septal myectomy and edge-to-edge mitral valve repair in obstructive hypertrophic cardiomyopathy.
    Mihos CG; Escolar E; Fernandez R; Nappi F
    Rev Cardiovasc Med; 2021 Dec; 22(4):1471-1477. PubMed ID: 34957786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitral annular calcification in obstructive hypertrophic cardiomyopathy: Incidence, risk factors, and prognostic value after myectomy.
    Wu Z; Nie C; Zhu C; Meng Y; Yang Q; Lu T; Lu Z; Liu X; Wang S
    Int J Cardiol; 2023 Nov; 391():131266. PubMed ID: 37574021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitral Valve Cleft-like Indentations in Hypertrophic Obstructive Cardiomyopathy: Insights From Intraoperative Three-Dimensional Transesophageal Echocardiography.
    Ye Z; Smith MM; Jouni H; Geske JB; Carney SA; Urina-Jassir M; Schaff HV; Enriquez-Sarano M; Michelena HI
    J Cardiothorac Vasc Anesth; 2022 Feb; 36(2):429-436. PubMed ID: 34176680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the best surgical treatment for obstructive hypertrophic cardiomyopathy and degenerative mitral regurgitation?
    Wan CK; Dearani JA; Sundt TM; Ommen SR; Schaff HV
    Ann Thorac Surg; 2009 Sep; 88(3):727-31; discussion 731-2. PubMed ID: 19699887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertrophic cardiomyopathy with moderate septal thickness and mitral regurgitation: long-term surgical results.
    Lapenna E; Nisi T; Carino D; Bargagna M; Ruggeri S; Zancanaro E; Del Forno B; Schiavi D; Agricola E; Castiglioni A; Alfieri O; De Bonis M
    Eur J Cardiothorac Surg; 2021 Jul; 60(2):244-251. PubMed ID: 33624799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of surgical expertise in septal myectomy for obstructive hypertrophic cardiomyopathy.
    Yu SN; Nakanishi K; Ginns JN; Salna MP; Shimada YJ; Polanco A; Chiang Y; Weiner SD; Takayama H
    Gen Thorac Cardiovasc Surg; 2020 Oct; 68(10):1094-1100. PubMed ID: 32103394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended septal myectomy for obstructive hypertrophic cardiomyopathy and its impact on mitral valve function.
    Lio A; D'Ovidio M; Chirichilli I; Saitto G; Nicolò F; Russo M; Irace F; Ranocchi F; Davoli M; Musumeci F
    J Cardiovasc Med (Hagerstown); 2024 Mar; 25(3):210-217. PubMed ID: 38251434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The surgical management of hypertrophic obstructive cardiomyopathy with the concomitant mitral valve abnormalities.
    Cui B; Wang S; Xu J; Wang W; Song Y; Sun H; Zheng Z; Lv F; Xiong H
    Interact Cardiovasc Thorac Surg; 2015 Dec; 21(6):722-6. PubMed ID: 26374266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained improvement after combined anterior mitral valve leaflet retention plasty and septal myectomy in preventing systolic anterior motion in hypertrophic obstructive cardiomyopathy in children.
    Delmo Walter EM; Siniawski H; Hetzer R
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):546-52. PubMed ID: 19464922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitral Regurgitation in Patients With Hypertrophic Obstructive Cardiomyopathy: Implications for Concomitant Valve Procedures.
    Hong JH; Schaff HV; Nishimura RA; Abel MD; Dearani JA; Li Z; Ommen SR
    J Am Coll Cardiol; 2016 Oct; 68(14):1497-504. PubMed ID: 27687190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First Experience With Percutaneous Mitral Valve Plication as Primary Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
    Sorajja P; Pedersen WA; Bae R; Lesser JR; Jay D; Lin D; Harris K; Maron BJ
    J Am Coll Cardiol; 2016 Jun; 67(24):2811-8. PubMed ID: 27311518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo mitral regurgitation as a cause of heart failure exacerbation in patients with hypertrophic cardiomyopathy.
    Kuperstein R; Klempfner R; Ofek E; Maor E; Freimark D; Sternik L; Goldenberg I; Raanani E; Arad M
    Int J Cardiol; 2018 Feb; 252():122-127. PubMed ID: 29174016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Mitral Regurgitation in Patients with Primary Hypertrophic Cardiomyopathy.
    Tesic M; Travica L; Giga V; Jovanovic I; Trifunovic Zamaklar D; Popovic D; Mladenovic D; Radomirovic M; Vratonjic J; Boskovic N; Dedic S; Nedeljkovic Arsenovic O; Aleksandric S; Juricic S; Beleslin B; Djordjevic Dikic A
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893516
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy: the edge-to-edge secures the correction of the systolic anterior motion.
    Obadia JF; Basillais N; Armoiry X; Grinberg D; Dondas A; Barthelet M; Derimay F; Rioufol G; Finet G; Pozzi M
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):638-643. PubMed ID: 28007871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitral Valve Disease in Hypertrophic Cardiomyopathy:Evaluation and Management.
    Jain CC; Newman DB; Geske JB
    Curr Cardiol Rep; 2019 Oct; 21(11):136. PubMed ID: 31673812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical Treatment for Hypertrophic Obstructive Cardiomyopathy with Concomitant Mitral Valve Abnormalities: A Cohort of 26 Cases.
    Song BR; Ren Y; Zhang HJ
    Heart Surg Forum; 2018 Nov; 21(6):E443-E447. PubMed ID: 30604666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of MitraClip for nonobstructive hypertrophic cardiomyopathy with mixed severe mitral valve regurgitation.
    Zeng J; Shu Q; Lu C; Wang Y
    ESC Heart Fail; 2023 Apr; 10(2):1454-1460. PubMed ID: 36669759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.